Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The potential of LINGO-1 as a therapeutic target for essential tremor.
Incidence of human herpesvirus 6 in clinical samples from Swedish patients with demyelinating diseases.
Urodynamics in the Evaluation of the Patient with Multiple Sclerosis: When Are They Helpful and How Do We Use Them?
Understanding intellectual enrichment: how cognitive reserve impacts on hippocampal volume in multiple sclerosis.
Alemtuzumab for the treatment of multiple sclerosis.
Changes of brain resting state functional connectivity predict the persistence of cognitive rehabilitation effects in patients with multiple sclerosis.
Neuropsychological, balance and mobility risk factors for falls in people with multiple sclerosis: a prospective cohort study.
[EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN ADULT RATS AFTER ADMINISTRATION OF INTERLEUKIN-1beta DURING DIFFERENT PERIODS OF EARLY LIFE].
The Elderly Person With Multiple Sclerosis: Clinical Implications for the Increasing Lifespan.
Basophils are dispensable for the recovery of gross locomotion after spinal cord hemisection injury.
DEMYELINATION/REMYELINATION AND EXPRESSION OF INTERLEUKIN-1β, SUBSTANCE P, NERVE GROWTH FACTOR, AND GLIAL-DERIVED NEUROTROPHIC FACTOR DURING TRIGEMINAL NEUROPATHIC PAIN IN RATS.
The Emerging Roles of Gamma-Delta T Cells in Tissue Inflammation in Experimental Autoimmune Encephalomyelitis.
Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.
New insights in the pathophysiology and treatment of multiple sclerosis spasticity and related symptoms. Foreword.
Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.
Vitamin d and multiple sclerosis: correlation, causality, and controversy.
Radiolabeled anti-aquaporin-4 protein antibody imaging: a valuable method for determining neuromyelitis optica.
Probenecid Application Prevents Clinical Symptoms and Inflammation in Experimental Autoimmune Encephalomyelitis.
What you cannot get from routine MRI of MS patient and why - The growing need for atrophy assessment and seeing beyond the plaque.
Longitudinal Relationships between Caloric Expenditure and Gray Matter in the Cardiovascular Health Study.
Small Molecule Inhibitor of Antigen Binding and Presentation by HLA-DR2b as a Therapeutic Strategy for the Treatment of Multiple Sclerosis.
Decision-making impairment in patients with multiple sclerosis: a case-control study.
Can neurotrophic cytokines help to regenerate the mammalian central nervous system?
Expression of a single ICAMâ1 isoform on T cells is sufficient for development of experimental autoimmune encephalomyelitis.
Employment needs of people with multiple sclerosis: a review of current literature and application to occupational therapy practice.

Pages